| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |